SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-075875
Filing Date
2024-06-21
Accepted
2024-06-21 07:30:32
Documents
96
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-K acst-20240331.htm   iXBRL 10-K 2966171
2 EX-21.1 acst-ex21_1.htm EX-21.1 3747
3 EX-23.1 acst-ex23_1.htm EX-23.1 2868
4 EX-23.2 acst-ex23_2.htm EX-23.2 3489
5 EX-31.1 acst-ex31_1.htm EX-31.1 13664
6 EX-31.2 acst-ex31_2.htm EX-31.2 13936
7 EX-32.1 acst-ex32_1.htm EX-32.1 10061
8 EX-32.2 acst-ex32_2.htm EX-32.2 10839
9 EX-97.1 acst-ex97_1.htm EX-97.1 60201
10 GRAPHIC img181340459_0.jpg GRAPHIC 53024
11 GRAPHIC img181340459_1.jpg GRAPHIC 19086
12 GRAPHIC img181340459_2.jpg GRAPHIC 101322
13 GRAPHIC img181340459_3.jpg GRAPHIC 14782
14 GRAPHIC img181340459_4.jpg GRAPHIC 68654
15 GRAPHIC img181340459_5.jpg GRAPHIC 56008
16 GRAPHIC img181340459_6.jpg GRAPHIC 41281
17 GRAPHIC img181340459_7.jpg GRAPHIC 173581
18 GRAPHIC img181340459_8.jpg GRAPHIC 164523
  Complete submission text file 0000950170-24-075875.txt   12047771

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acst-20240331.xsd EX-101.SCH 1466012
100 EXTRACTED XBRL INSTANCE DOCUMENT acst-20240331_htm.xml XML 1692237
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-35776 | Film No.: 241058348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)